News > Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

Dais Newsfeed | 28/12/2021 05:11 PM | Click to read full article

 Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 million doses as promised to the Centre, BE said on Tuesday.  

Corbevax, India’s first indigenously developed protein subunit vaccine, received approval from DGCI today.